137 related articles for article (PubMed ID: 3841194)
1. Administration of antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine attenuates ether-induced prolactin secretion in rats.
Kaji H; Chihara K; Kita T; Kashio Y; Okimura Y; Fujita T
Neuroendocrinology; 1985 Dec; 41(6):529-31. PubMed ID: 3841194
[TBL] [Abstract][Full Text] [Related]
2. Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats.
Kaji H; Chihara K; Abe H; Kita T; Kashio Y; Okimura Y; Fujita T
Endocrinology; 1985 Nov; 117(5):1914-9. PubMed ID: 3876209
[TBL] [Abstract][Full Text] [Related]
3. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.
Hagen TC; Arnaout MA; Scherzer WJ; Martinson DR; Garthwaite TL
Neuroendocrinology; 1986; 43(6):641-5. PubMed ID: 3762862
[TBL] [Abstract][Full Text] [Related]
4. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat.
Abe H; Engler D; Molitch ME; Bollinger-Gruber J; Reichlin S
Endocrinology; 1985 Apr; 116(4):1383-90. PubMed ID: 4038645
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effect of peptide histidine isoleucine amide 1-27 on prolactin release in the rat.
Kaji H; Chihara K; Abe H; Minamitani N; Kodama H; Kita T; Fujita T; Tatemoto K
Life Sci; 1984 Aug; 35(6):641-7. PubMed ID: 6431217
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role for prolactin-releasing peptide in prolactin secretion induced by ether stress and suckling in the rat: comparison with vasoactive intestinal peptide.
Watanobe H; Schiöth HB; Wikberg JE; Suda T
Brain Res; 2000 May; 865(1):91-6. PubMed ID: 10814736
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that peptide histidine isoleucine (PHI) may function as a prolactin releasing factor in rats.
Ohta H; Kato Y; Tojo K; Shimatsu A; Inoue T; Kabayama Y; Imura H
Peptides; 1985; 6(4):709-12. PubMed ID: 3934651
[TBL] [Abstract][Full Text] [Related]
9. Involvement of hypothalamic vasoactive intestinal polypeptide (VIP) in prolactin secretion induced by serotonin in rats.
Shimatsu A; Kato Y; Ohta H; Tojo K; Kabayama Y; Inoue T; Yanaihara N; Imura H
Proc Soc Exp Biol Med; 1984 Apr; 175(4):414-6. PubMed ID: 6709640
[TBL] [Abstract][Full Text] [Related]
10. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
Murai I; Reichlin S; Ben-Jonathan N
Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
[TBL] [Abstract][Full Text] [Related]
12. Helodermin stimulates prolactin secretion in the rat.
Koshiyama H; Kato Y; Inoue T; Christophe J; Yanaihara N; Imura H
Eur J Pharmacol; 1987 Sep; 141(2):319-21. PubMed ID: 3678365
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of vasoactive intestinal polypeptide and peptide histidine isoleucine on prolactin secretion by the bullfrog pituitary gland.
Koiwai K; Kikuyama S; Seki T; Yanaihara N
Gen Comp Endocrinol; 1986 Nov; 64(2):254-9. PubMed ID: 3493951
[TBL] [Abstract][Full Text] [Related]
14. Ether releases large amounts of prolactin from rat pituitaries previously "depleted" by short term suckling.
Grosvenor CE; Mena F; Whitworth NS
Endocrinology; 1979 Oct; 105(4):884-7. PubMed ID: 477601
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide.
Frawley LS; Neill JD
Neuroendocrinology; 1981 Aug; 33(2):79-83. PubMed ID: 7266772
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-releasing activity of porcine intestinal peptide (PHI-27).
Samson WK; Lumpkin MD; McDonald JK; McCann SM
Peptides; 1983; 4(6):817-9. PubMed ID: 6689504
[TBL] [Abstract][Full Text] [Related]
17. Effect of the peptide PHI-27 on prolactin release in vitro.
Werner S; Hulting AL; Hökfelt T; Eneroth P; Tatemoto K; Mutt V; Maroder L; Wünsch E
Neuroendocrinology; 1983 Dec; 37(6):476-8. PubMed ID: 6657006
[TBL] [Abstract][Full Text] [Related]
18. Novel effect of vasoactive intestinal polypeptide and peptide histidine isoleucine: inhibition of in vitro secretion of prolactin in the tilapia, Oreochromis mossambicus.
Kelley KM; Nishioka RS; Bern HA
Gen Comp Endocrinol; 1988 Oct; 72(1):97-106. PubMed ID: 3181742
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.
Maas DL; Martinson DR; Erdmann MD; Wahle JS; Hagen TC
Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
